

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.14385401 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.89047291 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.81444744 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.72480988 |
| 5 | complement activation, classical pathway (GO:0006958) | 5.68580898 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.29383166 |
| 7 | negative regulation of cell killing (GO:0031342) | 5.29383166 |
| 8 | positive regulation of respiratory burst (GO:0060267) | 5.21205986 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 4.96567773 |
| 10 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.88294384 |
| 11 | detection of bacterium (GO:0016045) | 4.84452961 |
| 12 | establishment of skin barrier (GO:0061436) | 4.78223976 |
| 13 | detection of other organism (GO:0098543) | 4.73613972 |
| 14 | complement activation (GO:0006956) | 4.68236306 |
| 15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.46083015 |
| 16 | leukocyte aggregation (GO:0070486) | 4.27901229 |
| 17 | immunoglobulin mediated immune response (GO:0016064) | 4.22112967 |
| 18 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.14649927 |
| 19 | cellular response to type I interferon (GO:0071357) | 4.13926420 |
| 20 | type I interferon signaling pathway (GO:0060337) | 4.13926420 |
| 21 | response to type I interferon (GO:0034340) | 4.11670970 |
| 22 | regulation of water loss via skin (GO:0033561) | 4.11191083 |
| 23 | germinal center formation (GO:0002467) | 4.11040335 |
| 24 | glomerular filtration (GO:0003094) | 3.97761468 |
| 25 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.88697947 |
| 26 | regulation of antigen processing and presentation (GO:0002577) | 3.81985710 |
| 27 | positive regulation of antigen processing and presentation (GO:0002579) | 3.76884602 |
| 28 | protein activation cascade (GO:0072376) | 3.75249892 |
| 29 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 3.59216973 |
| 30 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 3.55970963 |
| 31 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 3.55970963 |
| 32 | Fc-gamma receptor signaling pathway (GO:0038094) | 3.55970963 |
| 33 | regulation of respiratory burst (GO:0060263) | 3.55700626 |
| 34 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.54591549 |
| 35 | detection of external biotic stimulus (GO:0098581) | 3.53931850 |
| 36 | renal filtration (GO:0097205) | 3.51757341 |
| 37 | B cell mediated immunity (GO:0019724) | 3.50270025 |
| 38 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.46862255 |
| 39 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.46862255 |
| 40 | modulation by symbiont of host immune response (GO:0052553) | 3.46862255 |
| 41 | positive regulation by symbiont of host defense response (GO:0052509) | 3.46862255 |
| 42 | modulation by symbiont of host defense response (GO:0052031) | 3.46862255 |
| 43 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.46862255 |
| 44 | antimicrobial humoral response (GO:0019730) | 3.42354405 |
| 45 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.42120126 |
| 46 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.41366718 |
| 47 | neutrophil activation (GO:0042119) | 3.39220821 |
| 48 | dendritic cell chemotaxis (GO:0002407) | 3.36525509 |
| 49 | regulation of regulatory T cell differentiation (GO:0045589) | 3.35632466 |
| 50 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.32459823 |
| 51 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.30479863 |
| 52 | antibacterial humoral response (GO:0019731) | 3.29896705 |
| 53 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.27531827 |
| 54 | B cell receptor signaling pathway (GO:0050853) | 3.22167330 |
| 55 | regulation of T cell tolerance induction (GO:0002664) | 3.19568498 |
| 56 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.18481945 |
| 57 | macrophage activation involved in immune response (GO:0002281) | 3.16890896 |
| 58 | regulation of gamma-delta T cell activation (GO:0046643) | 3.12715067 |
| 59 | positive regulation of T cell migration (GO:2000406) | 3.10126469 |
| 60 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.08026685 |
| 61 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.07649758 |
| 62 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.07649758 |
| 63 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.07114996 |
| 64 | humoral immune response (GO:0006959) | 3.03691551 |
| 65 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.02487660 |
| 66 | regulation of tolerance induction (GO:0002643) | 3.02004950 |
| 67 | detection of biotic stimulus (GO:0009595) | 3.01906786 |
| 68 | cellular extravasation (GO:0045123) | 3.01814521 |
| 69 | regulation of T cell chemotaxis (GO:0010819) | 3.00947697 |
| 70 | positive regulation of T cell chemotaxis (GO:0010820) | 3.00947697 |
| 71 | negative regulation of interleukin-12 production (GO:0032695) | 3.00916708 |
| 72 | granulocyte activation (GO:0036230) | 2.98246964 |
| 73 | positive regulation of type 2 immune response (GO:0002830) | 2.96725085 |
| 74 | dendritic cell migration (GO:0036336) | 2.95411707 |
| 75 | response to interleukin-15 (GO:0070672) | 2.94783582 |
| 76 | regulation of mast cell degranulation (GO:0043304) | 2.91591886 |
| 77 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.91330289 |
| 78 | cellular response to interferon-gamma (GO:0071346) | 2.90996823 |
| 79 | regulation of T cell migration (GO:2000404) | 2.88026291 |
| 80 | positive regulation of B cell differentiation (GO:0045579) | 2.86606681 |
| 81 | negative regulation of innate immune response (GO:0045824) | 2.83330107 |
| 82 | negative regulation of T cell mediated immunity (GO:0002710) | 2.81831592 |
| 83 | myeloid cell activation involved in immune response (GO:0002275) | 2.80359625 |
| 84 | response to interferon-gamma (GO:0034341) | 2.79715302 |
| 85 | respiratory burst (GO:0045730) | 2.78706560 |
| 86 | positive regulation of lymphocyte migration (GO:2000403) | 2.78444043 |
| 87 | chronic inflammatory response (GO:0002544) | 2.77163766 |
| 88 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.74565632 |
| 89 | regulation of platelet aggregation (GO:0090330) | 2.73995123 |
| 90 | positive regulation of mast cell activation (GO:0033005) | 2.73685176 |
| 91 | regulation of cellular extravasation (GO:0002691) | 2.72473503 |
| 92 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.71881902 |
| 93 | response to interferon-beta (GO:0035456) | 2.71209690 |
| 94 | thrombin receptor signaling pathway (GO:0070493) | 2.69727942 |
| 95 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.69472533 |
| 96 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.68735207 |
| 97 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.67706171 |
| 98 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.67374391 |
| 99 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.67152495 |
| 100 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.65428231 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.93052201 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.55793303 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.36128904 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.90507939 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.79608603 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.44845000 |
| 7 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.15984145 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.11743201 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.93713016 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.85221562 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.79233758 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.71124233 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.37095960 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.32279041 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.25856982 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.23902802 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.19404064 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.17999211 |
| 19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.17692496 |
| 20 | SPI1_23127762_ChIP-Seq_K562_Human | 2.07873414 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.04377849 |
| 22 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.94884507 |
| 23 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.92202403 |
| 24 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.90095053 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.89675554 |
| 26 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89568794 |
| 27 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.88093214 |
| 28 | MYB_26560356_Chip-Seq_TH2_Human | 1.85524282 |
| 29 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.82814809 |
| 30 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.82638400 |
| 31 | MAF_26560356_Chip-Seq_TH1_Human | 1.81526648 |
| 32 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.78360208 |
| 33 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.74252066 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.72031828 |
| 35 | UTX_26944678_Chip-Seq_JUKART_Human | 1.69299918 |
| 36 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.68871110 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.66215434 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.65347388 |
| 39 | GATA1_22025678_ChIP-Seq_K562_Human | 1.64706847 |
| 40 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.64572680 |
| 41 | MYC_22102868_ChIP-Seq_BL_Human | 1.64443295 |
| 42 | GATA1_19941826_ChIP-Seq_K562_Human | 1.63546439 |
| 43 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.63017016 |
| 44 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.52483548 |
| 45 | MYB_26560356_Chip-Seq_TH1_Human | 1.52225665 |
| 46 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.47598187 |
| 47 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.46080276 |
| 48 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.43579715 |
| 49 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.40984568 |
| 50 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.39985350 |
| 51 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.38963524 |
| 52 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.37662464 |
| 53 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.37657250 |
| 54 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.36194699 |
| 55 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33853526 |
| 56 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33254726 |
| 57 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.31180344 |
| 58 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.30902782 |
| 59 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.28806432 |
| 60 | GATA2_19941826_ChIP-Seq_K562_Human | 1.28219428 |
| 61 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24988131 |
| 62 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.20782370 |
| 63 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.19004178 |
| 64 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.18791411 |
| 65 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.18083707 |
| 66 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15774199 |
| 67 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.14052202 |
| 68 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10477576 |
| 69 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.10371059 |
| 70 | MAF_26560356_Chip-Seq_TH2_Human | 1.07998454 |
| 71 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.07887892 |
| 72 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07717912 |
| 73 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.06573186 |
| 74 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.04292384 |
| 75 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03302994 |
| 76 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.01610128 |
| 77 | GATA3_26560356_Chip-Seq_TH2_Human | 1.00755490 |
| 78 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00392416 |
| 79 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99691727 |
| 80 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.95804328 |
| 81 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95122776 |
| 82 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95072805 |
| 83 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93498460 |
| 84 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93353153 |
| 85 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93329163 |
| 86 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.89043951 |
| 87 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.88533234 |
| 88 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86314159 |
| 89 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.85924041 |
| 90 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.85214916 |
| 91 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.83867642 |
| 92 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.83410533 |
| 93 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82228243 |
| 94 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.78440994 |
| 95 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.78257946 |
| 96 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.77480758 |
| 97 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77203607 |
| 98 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.75865857 |
| 99 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.74177689 |
| 100 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.74024969 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 5.18419336 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.82749152 |
| 3 | MP0003436_decreased_susceptibility_to | 3.46341472 |
| 4 | MP0005464_abnormal_platelet_physiology | 3.31877933 |
| 5 | MP0003303_peritoneal_inflammation | 3.26768788 |
| 6 | MP0000685_abnormal_immune_system | 3.05877528 |
| 7 | MP0005387_immune_system_phenotype | 3.03933071 |
| 8 | MP0001790_abnormal_immune_system | 3.03933071 |
| 9 | MP0005671_abnormal_response_to | 2.96016763 |
| 10 | MP0001800_abnormal_humoral_immune | 2.88883116 |
| 11 | MP0005025_abnormal_response_to | 2.65194687 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.64736933 |
| 13 | MP0010234_abnormal_vibrissa_follicle | 2.54473929 |
| 14 | MP0009785_altered_susceptibility_to | 2.52844999 |
| 15 | MP0000465_gastrointestinal_hemorrhage | 2.43557995 |
| 16 | MP0010155_abnormal_intestine_physiology | 2.43459770 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.40481297 |
| 18 | MP0002796_impaired_skin_barrier | 2.40252203 |
| 19 | MP0002723_abnormal_immune_serum | 2.33375259 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.33277325 |
| 21 | MP0002419_abnormal_innate_immunity | 2.32243562 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 2.29334971 |
| 23 | MP0004947_skin_inflammation | 2.24638778 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.19552325 |
| 25 | MP0003300_gastrointestinal_ulcer | 2.19544108 |
| 26 | MP0001819_abnormal_immune_cell | 2.17526974 |
| 27 | MP0003763_abnormal_thymus_physiology | 2.09498484 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 1.99295268 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.98804929 |
| 30 | MP0008004_abnormal_stomach_pH | 1.97502494 |
| 31 | MP0005275_abnormal_skin_tensile | 1.94791758 |
| 32 | MP0003866_abnormal_defecation | 1.79779172 |
| 33 | MP0006082_CNS_inflammation | 1.72684353 |
| 34 | MP0001851_eye_inflammation | 1.72141266 |
| 35 | MP0002398_abnormal_bone_marrow | 1.67709836 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.67012302 |
| 37 | MP0003566_abnormal_cell_adhesion | 1.66183470 |
| 38 | MP0000716_abnormal_immune_system | 1.63550382 |
| 39 | MP0003878_abnormal_ear_physiology | 1.58815217 |
| 40 | MP0005377_hearing/vestibular/ear_phenot | 1.58815217 |
| 41 | MP0004510_myositis | 1.52681214 |
| 42 | MP0002405_respiratory_system_inflammati | 1.50793876 |
| 43 | MP0003453_abnormal_keratinocyte_physiol | 1.41181645 |
| 44 | MP0002138_abnormal_hepatobiliary_system | 1.35535377 |
| 45 | MP0003828_pulmonary_edema | 1.35077418 |
| 46 | MP0003183_abnormal_peptide_metabolism | 1.33195729 |
| 47 | MP0002429_abnormal_blood_cell | 1.32457030 |
| 48 | MP0000858_altered_metastatic_potential | 1.32213775 |
| 49 | MP0000689_abnormal_spleen_morphology | 1.30225216 |
| 50 | MP0001873_stomach_inflammation | 1.29742826 |
| 51 | MP0002722_abnormal_immune_system | 1.27423266 |
| 52 | MP0005501_abnormal_skin_physiology | 1.26439618 |
| 53 | MP0000343_altered_response_to | 1.25536563 |
| 54 | MP0008260_abnormal_autophagy | 1.20497462 |
| 55 | MP0002277_abnormal_respiratory_mucosa | 1.18130235 |
| 56 | MP0005166_decreased_susceptibility_to | 1.17619208 |
| 57 | MP0005310_abnormal_salivary_gland | 1.16152024 |
| 58 | MP0001216_abnormal_epidermal_layer | 1.13625615 |
| 59 | MP0009764_decreased_sensitivity_to | 1.12819750 |
| 60 | MP0008469_abnormal_protein_level | 1.12095226 |
| 61 | MP0002166_altered_tumor_susceptibility | 1.11625287 |
| 62 | MP0004381_abnormal_hair_follicle | 1.10259515 |
| 63 | MP0001663_abnormal_digestive_system | 1.04861974 |
| 64 | MP0002998_abnormal_bone_remodeling | 1.00192833 |
| 65 | MP0000703_abnormal_thymus_morphology | 0.98017055 |
| 66 | MP0003448_altered_tumor_morphology | 0.96735842 |
| 67 | MP0009278_abnormal_bone_marrow | 0.96111565 |
| 68 | MP0005023_abnormal_wound_healing | 0.95601357 |
| 69 | MP0001545_abnormal_hematopoietic_system | 0.95234823 |
| 70 | MP0005397_hematopoietic_system_phenotyp | 0.95234823 |
| 71 | MP0003075_altered_response_to | 0.95025880 |
| 72 | MP0002132_abnormal_respiratory_system | 0.93930833 |
| 73 | MP0000579_abnormal_nail_morphology | 0.92211448 |
| 74 | MP0003045_fibrosis | 0.90753838 |
| 75 | MP0009763_increased_sensitivity_to | 0.90455650 |
| 76 | MP0000249_abnormal_blood_vessel | 0.90324307 |
| 77 | MP0005058_abnormal_lysosome_morphology | 0.87538593 |
| 78 | MP0010678_abnormal_skin_adnexa | 0.87013849 |
| 79 | MP0002933_joint_inflammation | 0.86808636 |
| 80 | MP0005390_skeleton_phenotype | 0.86549630 |
| 81 | MP0004264_abnormal_extraembryonic_tissu | 0.84789471 |
| 82 | MP0005409_darkened_coat_color | 0.83161166 |
| 83 | MP0009931_abnormal_skin_appearance | 0.79405623 |
| 84 | MP0000490_abnormal_crypts_of | 0.78176399 |
| 85 | MP0002396_abnormal_hematopoietic_system | 0.72289095 |
| 86 | MP0001958_emphysema | 0.71720229 |
| 87 | MP0004782_abnormal_surfactant_physiolog | 0.69823495 |
| 88 | MP0004883_abnormal_blood_vessel | 0.69737794 |
| 89 | MP0009765_abnormal_xenobiotic_induced | 0.68749495 |
| 90 | MP0000604_amyloidosis | 0.67114684 |
| 91 | MP0000377_abnormal_hair_follicle | 0.67104832 |
| 92 | MP0005164_abnormal_response_to | 0.66495786 |
| 93 | MP0010352_gastrointestinal_tract_polyps | 0.66279221 |
| 94 | MP0008874_decreased_physiological_sensi | 0.65124484 |
| 95 | MP0002133_abnormal_respiratory_system | 0.64450443 |
| 96 | MP0005388_respiratory_system_phenotype | 0.64450443 |
| 97 | MP0003091_abnormal_cell_migration | 0.63942059 |
| 98 | MP0005381_digestive/alimentary_phenotyp | 0.63939882 |
| 99 | MP0003806_abnormal_nucleotide_metabolis | 0.63873218 |
| 100 | MP0001853_heart_inflammation | 0.61845849 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 7.47238880 |
| 2 | Abnormality of nail color (HP:0100643) | 5.43766367 |
| 3 | Abnormality of macrophages (HP:0004311) | 4.78684474 |
| 4 | Increased IgE level (HP:0003212) | 4.73626340 |
| 5 | Prolonged bleeding time (HP:0003010) | 4.59589211 |
| 6 | Abnormality of the axillary hair (HP:0100134) | 4.32704959 |
| 7 | Abnormality of secondary sexual hair (HP:0009888) | 4.32704959 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 4.28661044 |
| 9 | Thick nail (HP:0001805) | 4.23503772 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 3.99975033 |
| 11 | Recurrent abscess formation (HP:0002722) | 3.92406641 |
| 12 | Purpura (HP:0000979) | 3.89915269 |
| 13 | Spontaneous hematomas (HP:0007420) | 3.81878361 |
| 14 | Urticaria (HP:0001025) | 3.62562946 |
| 15 | Petechiae (HP:0000967) | 3.62065947 |
| 16 | Epistaxis (HP:0000421) | 3.61325199 |
| 17 | Alopecia of scalp (HP:0002293) | 3.57115973 |
| 18 | Myositis (HP:0100614) | 3.52045563 |
| 19 | Gingival bleeding (HP:0000225) | 3.50571891 |
| 20 | Recurrent skin infections (HP:0001581) | 3.48775956 |
| 21 | Vasculitis (HP:0002633) | 3.43410340 |
| 22 | Meningitis (HP:0001287) | 3.32639117 |
| 23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.31159052 |
| 24 | Palmoplantar hyperkeratosis (HP:0000972) | 3.29689689 |
| 25 | Orchitis (HP:0100796) | 3.28134400 |
| 26 | Menorrhagia (HP:0000132) | 3.25198475 |
| 27 | Gastrointestinal infarctions (HP:0005244) | 3.18588159 |
| 28 | Chronic obstructive pulmonary disease (HP:0006510) | 3.18198787 |
| 29 | Obstructive lung disease (HP:0006536) | 3.18198787 |
| 30 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.08742321 |
| 31 | Palmar hyperkeratosis (HP:0010765) | 3.07765929 |
| 32 | Abnormal platelet volume (HP:0011876) | 3.06091180 |
| 33 | Retrobulbar optic neuritis (HP:0100654) | 3.05825619 |
| 34 | Optic neuritis (HP:0100653) | 3.05825619 |
| 35 | Agammaglobulinemia (HP:0004432) | 2.95410929 |
| 36 | Inflammation of the large intestine (HP:0002037) | 2.94700908 |
| 37 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.93386756 |
| 38 | Recurrent fungal infections (HP:0002841) | 2.91585619 |
| 39 | Gingivitis (HP:0000230) | 2.89741660 |
| 40 | Cellulitis (HP:0100658) | 2.88478503 |
| 41 | Plantar hyperkeratosis (HP:0007556) | 2.85954602 |
| 42 | Gastrointestinal stroma tumor (HP:0100723) | 2.85809792 |
| 43 | Malnutrition (HP:0004395) | 2.83146286 |
| 44 | Colitis (HP:0002583) | 2.82140245 |
| 45 | Mediastinal lymphadenopathy (HP:0100721) | 2.81889053 |
| 46 | Gastrointestinal inflammation (HP:0004386) | 2.80530206 |
| 47 | Pustule (HP:0200039) | 2.77903410 |
| 48 | Encephalitis (HP:0002383) | 2.75845621 |
| 49 | Premature loss of primary teeth (HP:0006323) | 2.73497212 |
| 50 | Keratoconjunctivitis sicca (HP:0001097) | 2.70322073 |
| 51 | Recurrent bronchitis (HP:0002837) | 2.68239805 |
| 52 | Panhypogammaglobulinemia (HP:0003139) | 2.68149657 |
| 53 | Hypergammaglobulinemia (HP:0010702) | 2.66803779 |
| 54 | Abnormality of the prostate (HP:0008775) | 2.65940082 |
| 55 | Increased mean platelet volume (HP:0011877) | 2.65856835 |
| 56 | Stomatitis (HP:0010280) | 2.65526889 |
| 57 | Prostate neoplasm (HP:0100787) | 2.64876932 |
| 58 | Increased IgM level (HP:0003496) | 2.63706113 |
| 59 | Chronic otitis media (HP:0000389) | 2.63147083 |
| 60 | Emphysema (HP:0002097) | 2.58472649 |
| 61 | Leukocytosis (HP:0001974) | 2.57643501 |
| 62 | Osteomyelitis (HP:0002754) | 2.57326384 |
| 63 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.55904428 |
| 64 | Chest pain (HP:0100749) | 2.54044349 |
| 65 | Recurrent cutaneous fungal infections (HP:0011370) | 2.53451283 |
| 66 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.53451283 |
| 67 | Recurrent viral infections (HP:0004429) | 2.52215984 |
| 68 | Keratoconjunctivitis (HP:0001096) | 2.45512429 |
| 69 | Right ventricular cardiomyopathy (HP:0011663) | 2.43847286 |
| 70 | Skin ulcer (HP:0200042) | 2.40797376 |
| 71 | Gangrene (HP:0100758) | 2.37797878 |
| 72 | Onycholysis (HP:0001806) | 2.36965981 |
| 73 | Hemoptysis (HP:0002105) | 2.35513759 |
| 74 | Skin rash (HP:0000988) | 2.34851974 |
| 75 | Abnormality of complement system (HP:0005339) | 2.33055851 |
| 76 | Oral leukoplakia (HP:0002745) | 2.32636099 |
| 77 | Pulmonary infiltrates (HP:0002113) | 2.32271234 |
| 78 | Glomerulonephritis (HP:0000099) | 2.24792193 |
| 79 | Impaired platelet aggregation (HP:0003540) | 2.22085149 |
| 80 | Abnormal platelet function (HP:0011869) | 2.22085149 |
| 81 | Autoimmune hemolytic anemia (HP:0001890) | 2.18563137 |
| 82 | Hypotrichosis (HP:0001006) | 2.17018152 |
| 83 | Joint swelling (HP:0001386) | 2.13988308 |
| 84 | Sepsis (HP:0100806) | 2.13626820 |
| 85 | Lymphopenia (HP:0001888) | 2.12369514 |
| 86 | Abnormality of T cell number (HP:0011839) | 2.11777516 |
| 87 | Arterial thrombosis (HP:0004420) | 2.11191386 |
| 88 | Abnormality of the nasal mucosa (HP:0000433) | 2.11060551 |
| 89 | Xerostomia (HP:0000217) | 2.09625771 |
| 90 | Recurrent sinusitis (HP:0011108) | 2.09118903 |
| 91 | Granulocytopenia (HP:0001913) | 2.08044855 |
| 92 | Villous atrophy (HP:0011473) | 2.07552991 |
| 93 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.07552991 |
| 94 | Nasal polyposis (HP:0100582) | 2.07022655 |
| 95 | Pulmonary embolism (HP:0002204) | 2.04693552 |
| 96 | Papilloma (HP:0012740) | 2.03297374 |
| 97 | Verrucae (HP:0200043) | 2.03297374 |
| 98 | Hyperlipoproteinemia (HP:0010980) | 2.03098724 |
| 99 | Erythroderma (HP:0001019) | 2.02923923 |
| 100 | Abnormal blistering of the skin (HP:0008066) | 2.01629461 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.64173599 |
| 2 | ERN1 | 3.72641145 |
| 3 | MAP4K1 | 3.70793703 |
| 4 | BLK | 3.21651248 |
| 5 | TYK2 | 3.15266420 |
| 6 | GRK6 | 2.34431325 |
| 7 | BTK | 2.34251418 |
| 8 | FES | 2.33978454 |
| 9 | CSK | 2.29362703 |
| 10 | ZAP70 | 2.24308784 |
| 11 | IRAK4 | 2.14202807 |
| 12 | FGFR4 | 2.08896272 |
| 13 | JAK1 | 2.07248504 |
| 14 | EPHB1 | 2.03246362 |
| 15 | TNK2 | 2.00540054 |
| 16 | JAK3 | 1.95752941 |
| 17 | IKBKE | 1.94431472 |
| 18 | SYK | 1.94298104 |
| 19 | EPHA3 | 1.90955324 |
| 20 | PRPF4B | 1.82858388 |
| 21 | CSF1R | 1.69443414 |
| 22 | MAP2K3 | 1.68327765 |
| 23 | TXK | 1.66068944 |
| 24 | KIT | 1.61160000 |
| 25 | HCK | 1.60757650 |
| 26 | LYN | 1.56463949 |
| 27 | FGR | 1.49867422 |
| 28 | TBK1 | 1.49472236 |
| 29 | MAP3K14 | 1.48567131 |
| 30 | TEC | 1.44759558 |
| 31 | FGFR3 | 1.40375371 |
| 32 | CDC42BPA | 1.39756234 |
| 33 | SIK3 | 1.39109384 |
| 34 | TGFBR1 | 1.37716881 |
| 35 | BMPR2 | 1.37099873 |
| 36 | JAK2 | 1.35569456 |
| 37 | IKBKB | 1.31193633 |
| 38 | BMX | 1.29435801 |
| 39 | TAOK1 | 1.17733923 |
| 40 | LCK | 1.17724803 |
| 41 | PIK3CG | 1.17242909 |
| 42 | IRAK1 | 1.12043094 |
| 43 | MAP3K3 | 1.11415553 |
| 44 | MAP3K6 | 1.09229809 |
| 45 | MAP3K1 | 1.07748906 |
| 46 | ITK | 1.06907108 |
| 47 | MAP3K13 | 1.05760570 |
| 48 | TAOK3 | 1.05267178 |
| 49 | NLK | 0.87534709 |
| 50 | SMG1 | 0.86977323 |
| 51 | MAP3K11 | 0.86171461 |
| 52 | MST4 | 0.85496521 |
| 53 | MATK | 0.85137761 |
| 54 | YES1 | 0.84298972 |
| 55 | RIPK1 | 0.83301141 |
| 56 | FER | 0.81480161 |
| 57 | RET | 0.80490562 |
| 58 | PTK2B | 0.79932248 |
| 59 | MYLK | 0.79856236 |
| 60 | FYN | 0.77625775 |
| 61 | STK24 | 0.77191193 |
| 62 | HIPK2 | 0.73163700 |
| 63 | MARK3 | 0.68978042 |
| 64 | PDK1 | 0.67243169 |
| 65 | GRK5 | 0.66847646 |
| 66 | MAPK7 | 0.64614160 |
| 67 | MAPK12 | 0.62886118 |
| 68 | PRKD2 | 0.62376654 |
| 69 | LRRK2 | 0.62145282 |
| 70 | PDPK1 | 0.61523857 |
| 71 | TRIB3 | 0.60499261 |
| 72 | PTK6 | 0.60090448 |
| 73 | TESK2 | 0.58094229 |
| 74 | PKN2 | 0.54952549 |
| 75 | TGFBR2 | 0.53768827 |
| 76 | MARK2 | 0.53666339 |
| 77 | ACVR1B | 0.51362925 |
| 78 | PRKCQ | 0.48724135 |
| 79 | MAP3K10 | 0.48349328 |
| 80 | PDGFRB | 0.47520598 |
| 81 | MAPKAPK2 | 0.44283103 |
| 82 | FGFR1 | 0.42237682 |
| 83 | PRKD1 | 0.42010844 |
| 84 | MST1R | 0.41595048 |
| 85 | ABL1 | 0.40248739 |
| 86 | MAP3K7 | 0.39983155 |
| 87 | MAP3K5 | 0.36444954 |
| 88 | PRKCD | 0.35615915 |
| 89 | STK10 | 0.35494557 |
| 90 | PRKG2 | 0.34000402 |
| 91 | TAOK2 | 0.32908684 |
| 92 | SIK1 | 0.31937965 |
| 93 | SIK2 | 0.31660013 |
| 94 | MAPK11 | 0.31644372 |
| 95 | KSR2 | 0.29880848 |
| 96 | ILK | 0.28511228 |
| 97 | DYRK1B | 0.26951794 |
| 98 | SRC | 0.26035626 |
| 99 | ADRBK1 | 0.25244350 |
| 100 | IRAK2 | 0.23911654 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.94999350 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.29185169 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.16570558 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.12075197 |
| 5 | Asthma_Homo sapiens_hsa05310 | 2.94858765 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.63116967 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.43933886 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.39276105 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.38254366 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.38039940 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.12271136 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.09260254 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 2.05251303 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.03149934 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.97219221 |
| 16 | Platelet activation_Homo sapiens_hsa04611 | 1.74519107 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.67240668 |
| 18 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.65817912 |
| 19 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.61871181 |
| 20 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.54151943 |
| 21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.53732471 |
| 22 | Influenza A_Homo sapiens_hsa05164 | 1.50448664 |
| 23 | Malaria_Homo sapiens_hsa05144 | 1.48044973 |
| 24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.43605858 |
| 25 | Measles_Homo sapiens_hsa05162 | 1.41814055 |
| 26 | Phagosome_Homo sapiens_hsa04145 | 1.41671290 |
| 27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.37093583 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.36862670 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.28111485 |
| 30 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.27128557 |
| 31 | Pertussis_Homo sapiens_hsa05133 | 1.26308176 |
| 32 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.25195510 |
| 33 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.17691366 |
| 34 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.17202050 |
| 35 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.08727685 |
| 36 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.05827756 |
| 37 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.05012283 |
| 38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.03905335 |
| 39 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.02221329 |
| 40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.01543664 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.97022135 |
| 42 | Hepatitis C_Homo sapiens_hsa05160 | 0.95887061 |
| 43 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.95795663 |
| 44 | Amoebiasis_Homo sapiens_hsa05146 | 0.93446198 |
| 45 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.92013339 |
| 46 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.90507816 |
| 47 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.87458531 |
| 48 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.86454646 |
| 49 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.85168029 |
| 50 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.80529938 |
| 51 | Legionellosis_Homo sapiens_hsa05134 | 0.79897869 |
| 52 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.79366958 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77570833 |
| 54 | Shigellosis_Homo sapiens_hsa05131 | 0.72615626 |
| 55 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.70454633 |
| 56 | Endocytosis_Homo sapiens_hsa04144 | 0.68125314 |
| 57 | Apoptosis_Homo sapiens_hsa04210 | 0.67582525 |
| 58 | Other glycan degradation_Homo sapiens_hsa00511 | 0.66619589 |
| 59 | Salmonella infection_Homo sapiens_hsa05132 | 0.65109286 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64196418 |
| 61 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.63547131 |
| 62 | Hepatitis B_Homo sapiens_hsa05161 | 0.63384807 |
| 63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.61162347 |
| 64 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60538847 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.58522707 |
| 66 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.57691565 |
| 67 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57144766 |
| 68 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54554706 |
| 69 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.52154574 |
| 70 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.49897475 |
| 71 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.49183829 |
| 72 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.48816580 |
| 73 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.48758045 |
| 74 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48381646 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44920487 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43735966 |
| 77 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.43609774 |
| 78 | Lysosome_Homo sapiens_hsa04142 | 0.42915638 |
| 79 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.42680487 |
| 80 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41820515 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41543114 |
| 82 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.41541677 |
| 83 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.40702640 |
| 84 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.40675424 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37232225 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36590633 |
| 87 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.35824469 |
| 88 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.34754030 |
| 89 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.34658743 |
| 90 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.33989456 |
| 91 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.33779521 |
| 92 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.33492858 |
| 93 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.32894361 |
| 94 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.31035040 |
| 95 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.27944957 |
| 96 | ABC transporters_Homo sapiens_hsa02010 | 0.26986952 |
| 97 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.26802041 |
| 98 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.26485907 |
| 99 | Focal adhesion_Homo sapiens_hsa04510 | 0.25521598 |
| 100 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.24791348 |

